Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review Follow us on Twitter
Join us on LinkedIn

Watch Cracking the Cancer Code

Watch Cracking the Cancer Code. What are the challenges in oncology drug development and commercialization, and how can we accelerate the process? In this four minute film, Quintiles experts talk about the importance of biomarkers, embedding market insights into the clinical development process earlier, and accelerating the timeline from molecule to medicine to marketplace.

What’s happening in oncology today heralds a new model of drug development for other therapeutic areas. See what’s coming—watch Cracking the Cancer Code at quintiles.com/newhealth

Whitepaper: Autoantibody biomarker panels for improved disease diagnosis

Oxford Gene TechnologySource: Oxford Gene Technology
Download this white paper for detailed insight into the advantages of autoantibodies as biomarkers, including a review of the current technology and best practices for identification of sensitive and specific autoantibody biomarkers.

Download now >>

Webinar: New monitoring methods improve compliance, reduce costs

Date: Tuesday 20 March 2012
Time: 3pm GMT
Length: 1 hour (incl. Q&A session)

Join us for presentations from some of the leading experts in the fields of monitoring and compliance and pharmaceutical water and cleanroom facility standards:

Regulation:
Breaking news on the revision of ISO 14644 and 14698

Water systems:
Using PAT guidelines for improved reliability of TOC monitoring for compendia water

Cleanrooms:
New paperless methods solve problems for monitoring airborne particles

Attendees will have the opportunity to ask questions during the Webinar which will be fielded by the presenters during a 15 minute Q&A.

Find out more >>

Company Directory

Premium & Premium+ listings:

- ABB Analytical Measurements
- Almac
- BD Diagnostics
- Bio-Optronics, Inc.
- bioMérieux
- BioTek Instruments, Inc.
- Bruker Daltonik GmbH
- CAMO Software AS
- CI Precision
- Cisbio Bioassays
- Colder Products Company
- Expo Technologies, LLC.
- Freeman Technology
- GE Analytical Instruments
- HACH LANGE GMBH
- HORIBA Scientific
- Hudson Robotics, Inc.
- Natoli Engineering Company, Inc.
- Peter Huber Kältemaschinenbau GmbH
- Randox Pharma Services
- Rapid Micro Biosystems
- Smithers Viscient
- Synbiosis
- Syngene
- Watson-Marlow Pumps Group

Add your company

U.S. FDA grants Priority Review for Truvada® for reducing the risk of acquiring HIV infection

Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration has accepted the supplemental New Drug Application and granted a six-month Priority Review for once-daily Truvada® (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxisto reduce the risk of HIV-1 infection...

Read the full story >>

 

More pharmaceutical & life science news

Study Shows Abbott’s Tacrolimus Assay Demonstrates Consistent Organ Transplant Drug Monitoring
Accurate and precise lab-to-lab monitoring is essential for long-term transplant success...

FDA approves ZIOPTAN™ (tafluprost ophthalmic solution)
ZIOPTAN™ (tafluprost ophthalmic solution) 0.0015%, the first preservative-absent prostaglandin analog ophthalmic solution...

FDA requests additional data on Novartis quadrivalent meningococcal conjugate vaccine, Menveo®
Novartis has received a Complete Response letter from the US FDA...

Bristol-Myers Squibb completes acquisition of Inhibitex, Inc.
Completion of the tender offer by Bristol-Myers for all of the outstanding shares of common stock of Inhibitex, Inc...

Lundbeck strengthens its European organization
Lundbeck bolsters its European organization with the appointment of João Rocha and Michael Quiqueran-Beaujeu...

Thomas E. Shenk to retire from Merck’s Board of Directors
Merck announced that Thomas E. Shenk, Ph.D., has decided to retire from its board of directors...

Sanofi and Bristol-Myers Squibb collect damages in Plavix patent litigation with Apotex
Apotex has made payment to Sanofi & Bristol-Myers Squibb...

FDA grants Roche’s pertuzumab Priority Review for previously untreated HER2-positive metastatic breast cancer
The U.S. FDA has accepted the company’s Biologics License Application for pertuzumab...

Amgen to discuss application for new use of XGEVA® (denosumab) at FDA ODAC meeting
Amgen to discuss the data from the sBLA for XGEVA® (denosumab)...

Abbott creates new Similac SimplySmart™ baby bottle
Abbott introduces Similac SimplySmart, an innovative BPA-absent baby bottle designed to improve the bottle feeding experience...

Merck announces top-line results of TRA-2P study of Vorapaxar
Company will review data from TRA-2P and TRACER with external experts to inform next steps...

Featured supplier news

The Asia flow chemistry system from Syrris, 320 configuration
Asia flow chemistry system heralds success for Syrris

Syrris is enjoying outstanding success with sales of Asia, its revolutionary range of advanced flow chemistry products.

Tecan and Artel partner to produce unique, fully integrated QC Kit for Freedom EVO® workstations
Tecan has partnered with Artel...

Syrris custom reactors – built for you
Syrris Custom Reactor Systems are ideally suited to processes requiring large reactor vessels...

B&W Tek to introduce spectral data acquisition software at SPIE’s BiOS & Photonics West Exhibits
B&W Tek, Inc., is proud to introduce BWSpec™ 4.00...

Conferences, events & exhibitions:

9th Annual PAT and Quality by Design
20 - 22 February 2012, London, UK

7th Annual Biomarkers Congress
22 - 23 February 2012, Manchester, UK

BIA Research & Development Conference
28 February 2012, London, UK

GDDIF 2012
7 - 8 March 2012, Budapest, Hungary

PITTCON 2012
11 - 15 March 2012, Orlando, FL, USA

2nd International Conference of the Flow Chemistry Society
13 - 14 March 2012, Munich, Germany

ADME and Predictive Toxicology
13 - 14 March 2012, Munich, Germany

The Drug Development Process – from Discovery to Commercialization
14 - 16 March 2012, Berlin, Germany

Biomarker Summit 2012
15 - 16 March 2012, San Diego, CA, USA

cGMP Quality Principles for Pharmaceuticals, Biopharmaceuticals, Biologics and Medical Devices
19 - 21 March 2012, Dublin, Ireland

8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
19 - 22 March 2012, Istanbul, Turkey

G Protein-Coupled Receptors in Drug Discovery
20 - 21 March 2012, Berlin, Germany